arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ZIMMER BIOMET HOLDINGS, INC.

ZBH
$96.61 ▼ -0.57 (-0.59%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
20 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

ZIMMER BIOMET HOLDINGS, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $19.1B
Dividend Yield 0.99%
Revenue Growth 7.2%
Op. Margin 13.3%
ROIC 4.7%
FCF / Share $7.44
Trailing P/E 27.1x
Price / Book 1.5x
FCF Yield 7.7%
Debt / Equity 0.55
info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$8.23B
↑ +7.2%
Net Income Profit after all expenses
$705.10M
↓ -22.0%
Operating Margin Operating profit as % of sales
13.3%
↓ -20.3% 64th
FCF / Share Free cash flow per share
$7.44
↑ +16.6%
Long-Term Debt Long-term obligations
$6.93B
↑ +29.8%

Health Breakdown

Profitability
68
Returns
55
Financial Health
58
Cash Quality
87

Dividend History

Dividend / share · sourced from SEC filings
$0.96 Latest / share
+0.0% YoY
+0.8% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 73 quarters